Company profile
Delfi Diagnostics company profile
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The company was founded in 2019 and is based in Baltimore, Maryland.
Business identity
- Website
- https://delfidiagnostics.com
- Contact email
- [email protected]
- Phone number
- 410-696-3304
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 101-250 employees
- Revenue range
- $1M-$10M
- Founded
- 2019-01-01, Year
Headquarters
- Headquarters
- Rosedale, Indiana, United States
- Postal code
- 21211
- Country code
- US
- Continent
- North America